PBK
TEVA icon

Peoples Bank (Kansas)’s Teva Pharmaceuticals TEVA Stock Holding History

Peoples Bank (Kansas)’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-87
Closed -$1.34K – 295
2025
Q1 		$1.34K Hold
87
– – ﹤0.01% 319
2024
Q4 		$1.92K Hold
87
– – ﹤0.01% 301
2024
Q3 		$1.57K Hold
87
– – ﹤0.01% 300
2024
Q2 		$1.41K Hold
87
– – ﹤0.01% 260
2024
Q1 		$1.23K Hold
87
– – ﹤0.01% 257
2023
Q4 		$908 Hold
87
– – ﹤0.01% 253
2023
Q3 		$887 Buy
+87
New +$810 ﹤0.01% 253

Other funds holding TEVA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
IAM
Ion Asset Management Herzliya, Israel $911M AUM 24.97% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $5.06B AUM 91.14% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Peoples Bank (Kansas)'s TEVA Position: Q2 2025 in Review

Peoples Bank (Kansas) sold out of Teva Pharmaceuticals (TEVA) in Q2 2025, closing a stake of 87 shares — an estimated $1.34K sold.

Peoples Bank (Kansas) first reported a position in TEVA in Q3 2023 and held it in 7 quarters. The position peaked at $1.92K in Q4 2024. 539 funds tracked by Wall St. Rank hold TEVA as of Q2 2025.

  • Peoples Bank (Kansas) reported no remaining Teva Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Peoples Bank (Kansas) sold 87 Teva Pharmaceuticals shares in Q2 2025, an estimated $1.34K.
  • Peoples Bank (Kansas) first reported a position in Teva Pharmaceuticals in Q3 2023 and held it in 7 quarters.
  • Peoples Bank (Kansas)'s Teva Pharmaceuticals position peaked at $1.92K in Q4 2024.
  • 539 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2025.

Based on Peoples Bank (Kansas)'s 13F filing for Q2 2025, filed 10 Jul 2025.